Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 5, 2010, Pages 2265-2268

  Simor, Andrew E ^a,b   Louie, Lisa ^a   Watt, Christine ^a   Gravel, Denise ^c   Mulvey, Michael R ^d   Campbell, Jennifer ^d   McGeer, Allison ^b,e   Bryce, Elizabeth ^f   Loeb, Mark ^g,t   Matlow, Anne ^h   Boyd, David ^d   Conly, John ⁱ   Embil, John ^j   Embree, Joanne ^j   Forgie, Sarah ^k   Frenette, Charles ^l   Gardam, Michael ^m   Henderson, Elizabeth ⁿ   Hutchinson, James ^o   John, Michael ^p   Johnston, Lynn ^q   Kibsey, Pamela ^r   Langley, Joanne ^s   Lemieux, Camille ^m   Michaud, Sophie ^u   Miller, Mark ^v   Moore, Dorothy ^w   Ofner Agostini, Marianne ^c   Pelude, Linda ^c   Roth, Virginia ^x   Suh, Kathryn ^x   Taylor, Geoffrey ^y   Thomas, Eva ^z   Thompson, William ^aa   Turgeon, Nathalie ^ab   Vayalumkal, Joseph ^ac   Vearncombe, Mary ^a   Weiss, Karl ^ad   Wong, Alice ^ae   Zoutman, Dick ^af   more..

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f VANCOUVER GENERAL HOSPITAL   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ FOOTHILLS HOSPITAL   (Canada)

^j HEALTH SCIENCES CENTRE   (Canada)

^k STOLLERY CHILDREN S HOSPITAL   (Canada)

^l MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^m UNIVERSITY HEALTH NETWORK   (Canada)

ⁿ Peter Lougheed Centre   (Canada)

^o Health Sciences Centre St John's   (Canada)

^p LONDON HEALTH SCIENCES CENTRE   (Canada)

^q QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^r VICTORIA GENERAL HOSPITAL   (Canada)

^s IWK HEALTH CENTRE   (Canada)

^t HAMILTON HEALTH SCIENCES   (Canada)

^u CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^v MCGILL UNIVERSITY   (Canada)

^w MONTREAL CHILDREN S HOSPITAL   (Canada)

^x UNIVERSITY OF OTTAWA   (Canada)

^y UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^z CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^aa Alberta Children's Hospital ^*  (Canada)

^ab LAVAL UNIVERSITY   (Canada)

^ac ALBERTA CHILDREN'S HOSPITAL   (Canada)

^ad MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^ae ROYAL UNIVERSITY HOSPITAL   (Canada)

^af KINGSTON GENERAL HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFTOBIPROLE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; POLYPEPTIDE ANTIBIOTIC AGENT; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANADA; CONTROLLED STUDY; HOSPITAL; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; CANADA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HOSPITALIZATION; HUMANS; INCIDENCE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PUBLIC HEALTH; STAPHYLOCOCCAL INFECTIONS;

EID: 77951235247     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01717-09     Document Type: Article

References (27)

1. Adam, H. J., L. Louie, C. Watt, D. Gravel, E. Bryce, M. Loeb, A. Matlow, A. McGeer, M. R. Mulvey, A. E. Simor, and the Canadian Nosocomial Infection Surveillance Program. 2010. Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995 to 2006. Antimicrob. Agents Chemother. 54:945-949.
2. Christianson, S., G. R. Golding, J. Campbell, the Canadian Nosocomial Infection Surveillance Program, and M. R. Mulvey. 2007. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 45:1904-1911.
3. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. M100-S19. Clinical Laboratory Standards Institute, Wayne, PA.
4. Deresinski, S. 2005. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin. Infect. Dis. 40:562-573.
5. Gilbert, M., J. MacDonald, D. Gregson, J. Siushansian, K. Zhang, S. Elsayed, K. Laupland, T. Louie, K. Hope, M. Mulvey, J. Gillespie, D. Nielsen, V. Wheeler, M. Louie, A. Honish, G. Keays, and J. Conly. 2006. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Can. Med. Assoc. J. 175:149-154.
6. Grundmann, H., M. Aires-de-Sousa, J. Boyce, and E. Tiemersma. 2006. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public health threat. Lancet 368:874-885.
7. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
8. Horan, T. C., M. Andrus, and M. A. Dudeck. 2008. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332.
9. Howden, B. P., and M. L. Grayson. 2006. Dumb and dumber - the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin. Infect. Dis. 42:394-400.
10. Howden, B. P., P. D. R. Johnson, P. B. Ward, T. P. Stinear, and J. K. Davies. 2006. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 50:3039-3047.
11. Limbago, B., G. E. Fosheim, V. Schoonover, C. E. Crane, J. Nadle, S. Petit, D. Heltzel, S. M. Ray, L. H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, W. Schaffner, Y. Mu, and S. K. Fridkin. 2009. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J. Clin. Microbiol. 47:1344-1351.
12. Liu, C., and H. F. Chambers. 2003. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob. Agents Chemother. 47:3040-3045.
13. Liu, C., C. J. Graber, M. Karr, B. A. Diep, L. Basuino, B. S. Schwartz, M. C. Enright, S. J. O'Hanlon, J. C. Thomas, F. Perdreau-Remington, S. Gordon, H. Gunthorpe, R. Jacobs, P. Jensen, G. Leoung, J. S. Rumack, and H. F. Chambers. 2008. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin. Infect. Dis. 46:1637-1646.
14. Louie, L., S. O. Matsumura, E. Choi, M. Louie, and A. E. Simor. 2000. Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus. J. Clin. Microbiol. 38:2170-2173.
15. Mulvey, M. R., L. Chui, J. Ismail, L. Louie, C. Murphy, N. Chang, M. Alfa, and the Canadian Committee for the Standardization of Molecular Methods. 2001. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J. Clin. Microbiol. 39:3481-3485.
16. Naimi, T. S., K. H. LeDell, K. Como-Sabetti, S. M. Borchardt, D. J. Boxrud, J. Etienne, S. K. Johnson, F. Vandenesch, S. Fridkin, C. O'Boyle, R. N. Danila, and R. Lynfield. 2003. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984.
17. Oliveira, D. C., and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2161.
18. Popovich, K. J., R. A. Weinstein, and B. Hota. 2008. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin. Infect. Dis. 46:787-794.
19. Rybak, M. J., S. N. Leonard, K. L. Rossi, C. M. Cheung, H. S. Sadar, and R. N. Jones. 2008. Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). J. Clin. Microbiol. 46:2950-2954.
20. Simor, A. E., N. L. Gilbert, D. Gravel, M. R. Mulvey, E. Bryce, M. Loeb, A. Matlow, A. McGeer, L. Louie, J. Campbell, and the Canadian Nosocomial Infection Surveillance Program. 2010. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national surveillance and changing epidemiology, 1995-2007. Infect. Control Hosp. Epidemiol. 31:348-356.
21. Simor, A. E., M. Ofner-Agostini, E. Bryce, K. Green, A. McGeer, M. Mulvey, S. Paton, and the Canadian Nosocomial Infection Surveillance Program. 2001. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. Can. Med. Assoc. J. 165:21-26.
22. Simor, A. E., M. Ofner-Agostini, E. Bryce, A. McGeer, S. Paton, M. R. Mulvey, and the Canadian Nosocomial Infection Surveillance Program. 2002. Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of national surveillance, 1995-1999. J. Infect. Dis. 186:652-660.
23. Simor, A. E., T. L. Stuart, L. Louie, C. Watt, M. Ofner-Agostini, D. Gravel, M. Mulvey, M. Loeb, A. McGeer, E. Bryce, A. Matlow, and the Canadian Nosocomial Infection Surveillance Program. 2007. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob. Agents Chemother. 51:3880-3886.
24. Tillotson, G. S., D. C. Draghi, D. F. Sahm, K. M. Tomfohrde, T. del Fabro, and I. A. Critchley. 2008. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study. J. Antimicrob. Chemother. 62:109-115.
25. Van De Griend, P., L. A. Herwaldt, B. Alvis, M. DeMartino, K. Heilmann, G. Doern, P. Winokur, D. D. Vonstein, and D. Diekema. 2009. Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA. Emerg. Infect. Dis. 15:1582-1589.
26. Wang, G., J. F. Hindler, K. W. Ward, and D. A. Bruckner. 2006. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J. Clin. Microbiol. 44:3883-3886.
27. Webster, D., R. P. Rennie, C. L. Brosnikoff, L. Chui, and C. Brown. 2007. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada. Diagn. Microbiol. Infect. Dis. 57:177-181.